EASL’s mission is to be the Home of Hepatology so all who are involved with treating liver disease can realise their full potential to cure & prevent it.

Dec 3, 2024 · Join us from 7–10 May 2025 in Amsterdam, the Netherlands, and online for the premier event in hepatology. The EASL Congress 2025 will bring together over 8,000 international delegates at the RAI Amsterdam, making it a unique platform for scientific exchange, collaboration, and learning.

East Asia Super League (EASL) is the champions league of East Asian basketball. Combining the best clubs, from the best leagues, with best-in-class production values, EASL’s vision is to become one of the world’s top professional basketball leagues.

Join leading experts from EASL, AASLD, ASCO, ILCA, regulatory agencies, and patient representatives for this pivotal consensus conference. Redefine clinical guidelines and explore innovative trial designs and endpoints shaping future HCC research and management.

Jun 21, 2022 · Major diagnostic and therapeutic innovations prompted the EASL Governing Board to commission specific Clinical Practice Guidelines on the identification, virologic and clinical characterisation, prognostic assessment, and appropriate clinical and therapeutic management of HDV-infected individuals.

Check out the latest East Asia Super League (EASL) standings! Track your favourite teams' rankings, points, and performance throughout the season.

Find out where to watch East Asia Super League (EASL) games live! Explore global broadcast partners and channels bringing the action straight to you.

EASL Congress 2025 is your gateway to connect with the global hepatology community. You will be joined by more than 8,000 like-minded peers in a buzzing event, where you can experience dynamic sessions, practical workshops, expert insights, numerous opportunities to …

Jun 7, 2024 · The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention, screening, diagnosis and treatment for MASLD.

Jan 16, 2024 · Four days of congress full of interactivity and hands-on learning sessions from world-class faculty. Excellent opportunities for the liver community to present their research, network and interact face-to-face with the greatest minds in hepatology. Visit the official website.

EASL 2024’s diverse scientific programme is tailored to various specialties and levels of expertise in hepatology. Explore our diverse lineup, which includes symposia, debates, workshops, ‘meet the expert’ sessions and much more, designed to enhance your understanding of the field.

There is a clear rationale for the management of ascites in patients with cirrhosis, as a successful treatment may improve the outcome and symptoms. A panel of experts was selected by the EASL Governing Board and met several times to discuss and write these guidelines during 2008–2009.

The European Association for the Study of the Liver (EASL) congress, Europe's largest event in hepatology, took place in Milan, Italy from 5 to 8 June 2024 in a hybrid format. This four-day event welcomed 7807 attendees from 118 countries, fostering research, education, scientific exchange and collaboration concerning the liver.

Regorafenib remains the standard and widely used second‐line strategy for advanced hepatocellular carcinoma (HCC). There is still a lack of large‐scale multicenter real‐world evidence concerning the concurrent use of regorafenib with immune checkpoint inhibitors (ICI).

EASL, the European Association for the Study of the Liver, founded in 1966, is a medical association dedicated to pursuing excellence in liver research, to the clinical practice of liver disorders, and to providing education to all those interested in hepatology.

Feb 1, 2022 · In order to increase the cure rate and disease-free survival rate of liver cancer, it is necessary to seek effective treatment methods. The objective of this study is to evaluate the therapeutic effects of IL-21 and IFN-γ inducing the formation of …

May 8, 2024 · Regorafenib remains the standard and widely used second-line strategy for advanced hepatocellular carcinoma (HCC). There is still a lack of large-scale multicenter real-world evidence concerning the concurrent use of regorafenib with …

Join us and become an active EASL member, part of the most forward-thinking and dynamic hepatology community in the world. Your participation as a member makes our association and our field of hepatology thrive.

May 23, 2024 · DATI can provide good to excellent image quality, effective venous blood signal suppression, and definitive thrombus detection for the diagnosis of AVT without the use of exogenous contrast agents. Discover the latest articles, news and stories from top researchers in related subjects.

Our well-respected EASL publications help spread knowledge and expertise in best practices and the latest scientific breakthroughs in hepatology to all those interested in liver-related diseases. Select EASL publication